In this paper, we propose a semi-parametric maximum likelihood estimate of an ROC curve that satisfies the property of invariance of the ROC curve. In our simulation studies, we demonstrate that the proposed estimator has the best performance among all the existing semi-parametric estimators considered here. Finally, we illustrate the application of the proposed estimator using a real data set.
Introduction
When the response of a diagnostic test is continuous, its diagnostic accuracy is best represented by the receiver operating characteristic (ROC) curve (Pepe, 2003; Zhou et al., 2002) . Let F 1 and F 0 denote distribution functions of the test result Y 1 for a diseased subject and the test result Y 0 for a non-diseased subject, respectively. Then, the ROC curve of the test can be written as
where
by assuming semi-parametric distributions for test results of diseased and non-diseased subjects.
One limitation of these methods is that none are a truly maximum likelihood (ML) estimator, and hence they do not possess the optimal property associated with ML estimators. Recently, Cai and Moskowitz (2004) , denoted by CM, have proposed a maximum profile likelihood approach to estimate the ROC curve; however, their computation algorithm requires an input of initial values of a large number of nuisance parameters, which may be difficult in practice when the sample size is large.
In this paper, we propose a new profile likelihood approach to estimate the ROC curve. Our method has a smaller number of nuisance parameters to estimate and hence may be more efficient than the Cai and Moskowitz method. Furthermore, our estimator can be computed by using an algorithm that is based on a recursive relationship among the nuisance parameters, without specifying initial values for a large number of nuisance parameters. Our MLE is asymptotically normal, and our extensive simulation studies show the proposed method is more efficient, more robust, and simpler to compute than the existing estimators.
Since the binormal model is the most commonly used form for an ROC curve, from now on we assume that the true ROC curve is defined by
where Φ −1 (·) is the inverse of the cumulative distribution of the standard normal distribution.
Equivalently, we can derive model (3) by assuming there exists an unknown monotone increasing function g (.) such that g(Y 0 ) has the standard normal distribution and g(Y 1 ) has a normal distribution with mean µ and standard deviation σ. The resulting ROC curve satisfies model (3) with α 0 = µ/σ and α 1 = 1/σ. This paper is organized as follows. In Section 2, we propose a semi-parametric maximum likelihood estimator of an ROC curve and an algorithm for computing it. In Section 3, we develop asymptotic properties for the resulting estimator. In Section 4, we perform simulation studies to asses efficiency and robustness of our estimator relative to the existing semi-parametric estimators and to verify the validity of the asymptotic inferences in finite samples. In Section 5, we illustrate the application of our method in a real example.
Data available for making inferences consist of a random sample of size n 1 from the diseased population with the unknown cumulative distribution function F 1 , {Y 1j , j = 1, · · · , n 1 }, and a random sample of size n 0 from the non-diseased population, {Y 0i , i = 1, · · · , n 0 }, with the unknown cumulative distribution function F 0 . Denote n = n 0 + n 1 .
Let f 0 and f 1 be the density functions of F 0 and F 1 , respectively. Then, the likelihood function
Under model (3), we know that there exists a unknown monotone increasing function g(.) such that g(Y 0 ) has the standard normal distribution and g(Y 1 ) has a normal distribution with mean µ and standard deviation σ. Therefore, we have that f 0 (y) = φ(g(y))g (y) and
. Hence we can write the likelihood function (4) as
where φ(x) is the standard normal density function. Consequently, the ML estimation of ROC curve parameters α 0 and α 1 requires simultaneous estimation of the unknown function g. In what follows we write g(x) as the jump of g(·) at x if g is discrete at x and the derivative of g(·) at x if g(·) is continuous at x. We seek to maximize the function L n given by
Using a standard argument in the nonparametric maximum likelihood estimation (Murphy and Van der Vaart, 2000) , we can restrict the MLE, g, of g to be the maximiser of the likelihood function L n over all discrete functions g and show that the MLE, g, has to be a discrete function that only jumps at observations Y 0i , i = 1, · · · , n 0 , and Y 1j , j = 1, · · · , n 1 . Denote the distinct ordered test results from the combined sample, Y 0i 's and
, and we can write the likelihood function (6) as follows:
φ(g(Y corresponding to non-diseased and diseased subjects at distinct ordered test results.
(r) ), C * 0 = −∞, and C * I * n = +∞, we can write (7) as
when g = g. Therefore ML estimation of ROC curve parameters α 0 and α 1 , which are of primary interest, requires simultaneous estimation of the I * n −1 number of nuisance parameters, C * 1 , · · · , C * I * n −1 . Using the same idea as in Metz (1998) , we note that some of the jump points of g, Y * (r) 's, can be ignored for estimating α 0 and α 1 , which means we can obtain ML estimates of α 0 and α 1 with fewer nuisance parameters. We state the results in Conclusion 1 below.
Each jump point in has the same disease status as its next contiguous jump point. Here, includes all jump points of a contiguous sequence with the same disease status except the last point in the sequence.
Conclusion 1.
The maximum likelihood estimates of α 0 and α 1 can be determined by some estimating equations that don't depend on those nuisance parameters C *
belongs to .
See Appendix A.1 for a proof of Conclusion 1. A practical consequence of the conclusion is that we can ignore the jump points in for estimating α 0 and α 1 .
After deleting the points in , we denote the remaining jump points of g by
which is essentially (8) with I * n replaced by I n . Here, for 2 ≤ r
It should be noted that the function (9) is the same as the likelihood proposed by Metz et al (1998) . However, Metz et al. (1998) the number of categories, I n , increases with the sample size, and as a result, the assumed standard multinomial distribution does not hold. Therefore, although Metz et al. (1998) have derived a correct likelihood function form, their justification is not right. Furthermore, to maximize the likelihood function (9) with respect to θ and C, Metz et al. (1998) have used the standard Newton-Raphson iterative method that requires inversion of an (I n + 1) × (I n + 1) matrix; this computation can become a problem if I n is large. Due to this concern, they have proposed an alternative algorithm by reducing the number of jump points, I n − 1, in an ad hoc way. Hence, their resulting estimate of θ is no longer a ML estimate, and our simulation studies show the ad hoc computation method can lead to some loss of efficiency.
We propose a new algorithm for finding ML estimates based on the function (9). We propose a two-stage iterative procedure for estimating θ and C, alternating the parametric and nonparametric estimation steps. Our idea is from Kvam and Samaniego (1994) on the nonparametric estimation.
Given θ, we can find the MLE of C by maximizing the likelihood function (9) with respect to C. The MLE of C must satisfy the following (I n − 1) score equations:
Given θ, the existence and uniqueness of the MLE of C are established in the following result, and a proof is given in the Appendix A.2.
Conclusion 2. Given θ, the C that satisfies the score equations in (10) is unique.
Inspection of (10) shows that finding the MLE of C in a closed form is a challenge. Hence, an iterative algorithm is required. However, the standard Newton-Raphson iteration requires inversion of an (I n − 1) × (I n − 1) matrix, and this computation can become a problem if I n is large.
Now we make use of the uniqueness in Conclusion 2 to solve the equations (10). Note that r k r = 0, for 1 ≤ r ≤ I n ; r r+1 = 0 and k r k r+1 = 0 for 1 ≤ r ≤ I n − 1. Suppose that we have selected an initial value of C 1 ,Č 1 . Then from the first equation of (10), we obtain an estimate,Č 2 ,
For r = 2, · · · , I n − 2, using the latest estimates,Č r−1 andČ r , of C r−1 and C r , we solve the rth equation of (10) to obtain the following estimate of C r+1 :
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Hence, given the initially chosen value of C 1 ,Č 1 , we can obtain the estimates,Č 2 , . . . ,Č I n −1 , of C 2 , . . . , C In−1 by solving the first I n − 2 equations in (10). Now we are left to check whether these estimates also satisfy the last equation in (10),
where Let θ 0 be the true value of θ and g 0 be the true function of g. Denote C r0 = g 0 (lim n→∞ Y (r) ) and
T . In the following Conclusion 3, we establish the relationship between C 1 and Λ(C In−2 , C In−1 ) to help in updating the initially chosen value,Č 1 . We provide a proof for Conclusion 3 in the Appendix A.3.
be the corresponding solution to the first (I n − 2) equations in (10). Then, when n is large enough, 1. ifČ 1 < C 10 , thenČ r < C r0 for r = 2, · · · , I n − 1, and
2. ifČ 1 > C 10 , thenČ r > C r0 for r = 2, · · · , I n − 1, and
The results of Conclusion 3 provide a mechanism for updating the initially chosen valueČ 1 .
If Λ(Č I n −2 ,Č I n −1 ) > 0, we should increase our initially chosen value,Č 1 . On the other hand, if
we should decrease our initially chosen value,Č 1 .
Given C, we can estimate θ by maximizing (9). We next outline the two-stage iterative procedure for estimating θ and C.
• Step 1. We combine data from the diseased and non-diseased samples and order test results in the combined sample, replace each test result by its true disease status. no, di, no, di, di, di, di}, where no and di indicate a non-diseased and diseased subject, respectively. Thus, in the above notation, we have I n = 4
and k 1 = 2, k 2 = 0, k 3 = 1, k 4 = 0 and 1 = 0, 2 = 1, 3 = 0, 4 = 4.
• Step 2. Given values of α 0 , α 1 , we estimate C 1 , · · · , C I n −1 by solving (10).
• Step 3. Given estimates of C 1 , · · · , C I n −1 , we estimate α 0 and α 1 by maximizing (9) with respect to α 0 and α 1 .
• Step 4. Repeat Steps 2 and 3 until two successive values for
Asymptotic distribution theory
Our final estimate θ of θ is a profile likelihood estimate, which maximizes the profile likelihood for θ given by
where C(θ) maximizes the likelihood L n (θ, C) for a fixed value of θ. This estimator is a function of the test values only through their ranks. Using the results on the properties of maximum profile likelihood estimates derived by Murphy and Van der Varrt (2000) , we can show that θ is fully efficient and n 1/2 ( θ − θ 0 ) converges in distribution to a zero-mean bivariate normal random vector with covariance matrix Σ, where
Based on the estimates of α 0 and α 1 , we can estimate the ROC curve by ROC(u) = Φ( α 0 + 
where Σ is defined by (12), α 00 , and α 10 are the true values of α 0 and α 1 , respectively.
Numerical studies
In this section we conduct several simulation studies to (1) determine if our estimator is more efficient than the five existing estimators, (2) assess the robustness of our estimator against the departure from the binormal model, and (3) evaluate the accuracy of the asymptotical variance estimator of our estimator in finite sample sizes.
· 1 Efficiency
In this subsection we investigate the statistical efficiency of the six methods: the proposed method (MLE), CM, MHS, AP, PC and ZH methods for estimating α 0 and α 1 in the binormal model and for estimating the corresponding ROC curve by numerical studies. We use the root of mean squared error (RMSE) to measure the performance of the various estimators for α 0 and α 0 and the sum of RMSEs for α 0 and α 1 as an overall performance measure. We evaluate the performance of an estimator ROC(·) for the ROC curve using the average of squared errors (ASE), defined by
where {u k , k = 1, · · · , n grid } are the grid points at which the functions ROC(·) are estimated. In the simulation studies, we choose n grid = 100 and u k 's to be uniformly distributed over (0, 1). We choose 500 simulations for each scenario. Data for non-diseased subjects are generated from the standard normal distribution, and data for diseased subjects are generated from N (2, 1.44). We choose sizes of the diseased and non-diseased samples to be both equal and unequal, (n 0 , n 1 ) = {(100, 100), (200, 100), (200, 200)}, to investigate the effect of the sample sizes on the performance of the estimates. Table 1 gives bias, SD, RMSE and SRMSE of the resulting estimators for α 0 and α 1 by the six methods. From Table 1 we see that in all cases, our new MLE has the smallest SRMSE and is the best choice. Specifically, our MLE consistently has smaller bias, standard error, and RMSE than the CM estimator due to a smaller number of nuisance parameters to estimate. Although the PC can have the smallest variance, its bias is also large and can even be larger than its variance, which means that the bias is significant and could not be ignored; the AP estimator is less biased than the PC estimator but has a larger variance than the PC estimator. The ZH estimator has the largest RMSE and bias. Figure 1 depicts the distribution of the estimated ASE for the ROC curve over the 500 replications for each method. The MLE and CM estimators have comparable ASE, which is smaller than the other existing methods. The performance of the estimators MHS and AP is close to that of our MLE in this setting. Further simulation study (not reported here) shows that when the accuracy of a diagnostic test is not too high or the sample size is large so that I n can be large, the computation algorithm in the MHS method, which collapses too many jump points, can lead to some loss of efficiency. The AP estimator has smaller ASE than the PC estimator, and the ZH estimator has the largest ASE.
In summary, the existing CM, MHS, and AP estimators have similar efficiency as our ML estimator with the ML estimators being slightly better. The ZH estimators have the worst performance.
· 2 Robustness
In the subsection, we compare the robustness of the six methods against the departure from the binormal assumption.
One anonymous reviewer has suggested that it may be reasonable to expect a transformation to result in approximate normal data for non-diseased subjects, but since the population of diseased subjects is often a mixture of subpopulations of subjects in different stages of the disease/infection, it seems much more reasonable to expect that transformation would result in a and N (2.2, 1.5 2 ), with the corresponding mixing proportions of 1/2 and 1/2, respectively. We set (n 0 , n 1 ) = {(100, 100), (200, 200) } to investigate the effect of the sample sizes on the performance of the estimates. The AP estimator has better ASE than the PC estimator, which means the AP estimator is more robust than the PC estimator. The ZH estimator has the largest ASE.
We also conduct numerical studies with a larger number of the components in a normal mixture.
We generate test results of non-diseased subjects from the standard normal distribution but test results of diseased subjects from a mixture of the three normal distributions, N (1.2, 1.2 2 ), N (2.2, 1.5 2 )
and N (2.2, 1), with the corresponding mixing proportions of 1/3, 1/3, and 1/3, respectively. The results (not reported here) are similar to those in Figures 2 and 3 except that the PC estimator seems to have the largest bias and ASE, suggesting that the robustness of the PC estimator may decrease as the number of components in normal mixtures increases.
In summary, the existing CM, MHS, and AP estimators have similar robustness as our ML estimators even though the ML estimators are slightly better.
· 3 Asymptotic inference in finite sample
Finally, we assess the accuracy of our variance estimator given in Section 3 in finite sample sizes. We investigate the performance of our variance estimator using the simulated data in Sections 5.1 and 5.2. Based on 500 simulated data sets, we obtain 500 estimates of α 0 and α 1 and their corresponding Table 2 : Average (SE ave ) and standard deviation (SE std ) of the standard error estimates over the 500 replications for the binormal simulated data in Section 4.1 Table 3 : Average (SE ave ) and standard deviation (SE std ) of the standard error estimates over the 500 replications for the mixture normal data in Section 4.2 standard error estimates using our method. From ML estimates of α 0 and α 1 , we form the empirical standard deviations, denoted by SD, which can be regarded as an approximation to the true standard deviations. We denote the average and the standard deviation of 500 estimated standard errors for the estimated α 0 and α 1 by SE ave and SE std , respectively, which summarize the overall performance of the standard error estimator. We report our results in Table 2 for the simulated binormal data and in Table 3 for the simulated mixture normal data, respectively. The standard error estimators are very close to the "true" sample standard errors. The empirical CI coverage probabilities are close to their nominal levels. In this section we illustrate the application of our newly proposed method in a real example on the accuracy of biomarkers for detecting pancreatic cancer (Wieand et al., 1989) . This study examined two biomarkers, the antigenic determinant, designated as CA125, and carbohydrate antigen designated as CA19-9. The data consist of 51 measurements on subjects free of disease and 90 measurements on diseased subjects using the two biomarkers. Here, we used the results with CA125
to illustrate the application of our methodology.
Although the binormal ROC model (3) possesses a certain degree of robustness against normal mixtures, as shown in the simulation study, it is also important to assess whether the binormal model (3) is appropriate for the data before we make inferences on the ROC curve of the CA125 using the binormal model. Here, we present a graphical method to test model (3).
To detect any large discrepancies in fit, we compare the empirical ROC curve with the MLE of the ROC curve obtained by substituting ML estimates of α 0 , α 1 into model (3). Figure 6 (b) plots the estimated ROC curves using the six methods. The MLE, CM, and MHS estimates are quite similar and are distinct from the others. We also note that the ZH estimate is substantially different from the rest.
Discussion
In this paper we have proposed a semi-parametric MLE for the ROC curve under the binormal ROC curve model (3). The ML estimator is asymptotically normal. The asymptotic results also hold for Hanley (1988) has shown that the binormal ROC curve model for ordinal-scale tests enjoys a certain degree of robustness against departure from the bi-normality assumption. Our own simulation studies have also demonstrated this result. However, given limitations of any simulation study, we want to emphasize that it is important to check the assumption of the bi-normality in any application; for example one may use the graphical method suggested in Section 5.
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Proof of Conclusion 1
Let λ n (θ, 
for 1 ≤ r ≤ I * n − 1, and
and ∂λ n (θ, C * ) ∂θ = 1 n
respectively, where k r and r are defined in Section 2. Note that (16) and (17) 
A.2 Proof of Conclusion 2
where By (18) and (19), we have Using the same argument as before withČ 1 = C 10 + ε, we can obtain the first part of Conclusion 3.
